Health care reform: How personalized medicine could help bundling of care for liver diseases
Lopa Mishra – 27 January 2011
Erratum: Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells
Zixue Jin, Rui Sun, Haiming Wei, Xiang Gao, Yongyan Chen, Zhigang Tian – 27 January 2011
Association between virological response and decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in HCV genotype 1: another story
Chia‐Yen Dai, Chung‐Feng Huang, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu – 27 January 2011
Lineage tracing demonstrates no evidence of cholangiocyte epithelial‐to‐mesenchymal transition in murine models of hepatic fibrosis
Andrew S. Chu, Rosalyn Diaz, Jia‐Ji Hui, Kilangsungla Yanger, Yiwei Zong, Gianfranco Alpini, Ben Z. Stanger, Rebecca G. Wells – 27 January 2011 – Whether or not cholangiocytes or their hepatic progenitors undergo an epithelial‐to‐mesenchymal transition (EMT) to become matrix‐producing myofibroblasts during biliary fibrosis is a significant ongoing controversy.
Survival of the fittest: Selection of hepatitis C virus variants during liver graft reinfection
Ingmar Mederacke, Thomas von Hahn – 27 January 2011
Utilization of elderly donors in living donor liver transplantation: When more is less?
Murat Dayangac, C. Burcin Taner, Onur Yaprak, Tolga Demirbas, Deniz Balci, Cihan Duran, Yildiray Yuzer, Yaman Tokat – 25 January 2011 – An accepted definition of donor exclusion criteria has not been established for living donor liver transplantation (LDLT). The use of elderly donors to expand the living donor pool raises ethical concerns about donor safety. The aims of this study were (1) the comparison of the postoperative outcomes of living liver donors by age (≥50 versus <50 years) and (2) the evaluation of the impact of the extent of right hepatectomy on donor outcomes.
Liver transplantation for propionic acidemia in children
Roshni Vara, Charles Turner, Helen Mundy, Nigel D. Heaton, Mohammed Rela, Giorgina Mieli‐Vergani, Mike Champion, Nedim Hadzic – 25 January 2011 – Propionic acidemia (PA) is a rare inherited disorder of branched chain amino acid metabolism; despite improvements in conventional medical management, the long‐term outcome remains disappointing. Liver transplantation (LT) has been proposed to minimize the risk of further metabolic decompensations and to improve the quality of life. We performed a retrospective review of all children with PA who underwent LT between 1987 and 2008.
Small‐for‐size donor syndrome?
J. Michael Millis – 25 January 2011
Predictors of cardiovascular events after liver transplantation: A role for pretransplant serum troponin levels
Elizabeth Coss, Kymberly D. S. Watt, Rachel Pedersen, Ross Dierkhising, Julie K. Heimbach, Michael R. Charlton – 20 January 2011 – Cardiovascular complications are major causes of morbidity and mortality after liver transplantation. Identifying candidates at highest risk of postoperative complications is a cornerstone of optimizing outcomes and utility.
Optimizing outflow in piggyback liver transplantation without caval occlusion: The three‐vein technique
Claude Tayar, Michael D. Kluger, Alexis Laurent, Daniel Cherqui – 20 January 2011